Higher ethylene oxide (EtO) exposure is significantly associated with an increased risk of stroke in U.S. adults, particularly those under 50 years old. Highlights: Higher levels of EtO are linked to increased stroke rates, with individuals in the top 25% of exposure showing a stroke prevalence 1.6 times higher than those in the bottom 25%. …
Nanoparticle-enhanced radiotherapy (NERT) is a promising approach to improving brain tumor treatment by enhancing radiotherapy efficacy through targeted delivery and radiosensitization while overcoming challenges posed by the blood-brain barrier. Highlights: Mechanisms of Action: NERT utilizes nanoparticles (NPs) as radiosensitizers, enhancing radiation-induced damage through physical dose enhancement and biological/chemical sensitization. Types of Nanoparticles: Various NP types, …
Lithium shows promise in treating traumatic brain injury (TBI) by mitigating neuroinflammation, protecting against neuronal damage, and improving cognitive functions. Highlights: Neuroprotective Mechanisms: Lithium’s therapeutic effects involve complex molecular mechanisms including gene expression, neurotransmitter signaling, and circadian modulation, contributing to neuronal protection and recovery post-TBI. Targeted Brain Regions: Post-treatment, lithium concentrations are notably higher in …
The study demonstrated that selegiline (SEL) improves memory performance, reduces anxiety, and modulates oxidative stress in an Alzheimer’s disease (AD) rat model. Highlights: Memory Improvements: SEL administration improved recognition memory, spatial memory, and passive avoidance memory in AD rats. Anxiety Reduction: SEL significantly reduced anxiety-like behavior in AD rats, as evidenced by performance in the …
Repurposing antipsychotics and antidepressants with favorable safety profiles and blood-brain barrier permeability shows promise for glioblastoma (GBM) treatment, primarily through disrupting lysosomal function and inducing cell death. Highlights: Mechanism of Action: The studied antipsychotics and antidepressants induce GBM cell death by disrupting lysosomal function, leading to lysosomal membrane rupture. PTEN Sensitivity: GBMs with intact PTEN …
This study shows that type 2 diabetes causes decreased blood flow and changes in neural activity in specific parts of the hippocampus, which may initially compensate for cognitive decline but deteriorate with worsening diabetes. Highlights: Decreased Perfusion: Patients with type 2 diabetes have lower blood flow in the right hippocampal CA1, DG, and subiculum areas. …
A study found that adults recovering from their first COVID-19 infection more than 1-year ago have higher levels of fatigue and other chronic neuropsychiatric symptoms, influenced by vaccination status and socioeconomic factors. Highlights: Adults who had their first COVID-19 infection over 1-year ago reported significantly higher fatigue levels compared to those who never had COVID-19 …
The naturally occurring peptide BPC 157 shows potential to treat stroke, schizophrenia symptoms, and spinal cord injury in animal models. Key facts: BPC 157 rapidly counteracted stroke damage and led to full recovery of memory, coordination and movement in rats. The peptide alleviated schizophrenia-like symptoms and catalepsy in rodent models by modulating dopamine, glutamate and …
Traumatic brain injury (TBI) has been called the “signature injury” of recent conflicts in Iraq and Afghanistan. TBIs are concerning because they can cause long-term issues like headaches, memory problems, and trouble thinking clearly. A new study looked at which military jobs put service members most at risk for TBIs. It found that certain combat-related …
Researchers have found signs of ongoing inflammation in the brains of athletes still experiencing concussion symptoms months or years after their injury, according to a new study published in Journal of Neuroinflammation. The findings suggest the concussion triggered chronic neuroinflammation that may be contributing to their persistent symptoms. Key Facts: The study examined athletes who …
